| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.32 | 0.05 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.32 | 0.06 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.3 | 0.06 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.24 | 0.0001 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.008 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.03 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |